Bottom line
What is ECVAX's expense ratio?
ECVAX's expense ratio is 1.51%, or about $151 a year on every $10,000 invested. That is more expensive than 91% of municipal bond funds we track (median 0.63%). It has no front-end sales load. Its expense ratio includes a 0.95% 12b-1 marketing fee.
Updated Dec 23, 2025
ECVAX fee table
| Net expense ratio | 1.51% |
|---|---|
| Gross expense ratio | 1.51% |
| Management fee | 0.29% |
| 12b-1 (distribution) fee | 0.95% |
| Other expenses | 0.27% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What ECVAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| ECVAX | $254 | $477 | $824 | $1,599 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.51% expense ratio costs roughly $80,000 in lost growth, versus about $36,000 for the median municipal bond fund (0.63%).